Test identifies patients at risk for severe organ rejection, say Univ. of Pittsburgh researchers
Researchers developed an ELISA test that accurately identifies patients with sensitized immune systems, increasing the chances of preventing rejection in pediatric heart transplant patients. The test has shown promising results in lung transplant patients as well, suggesting its potential to become a routine clinical care tool.